Harrow is a Nashville, Tennessee-based pharmaceutical provider that entered into an agreement to acquire the Tyrvaya dry eye treatment from Viatris Inc.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Tyrvaya Dry Eye Treatment From →Already a subscriber? Sign in
Xcout Intel tracks Tyrvaya Dry Eye Treatment From continuously — this profile deepens as new filings, funding, people and hiring data arrive.